Protein Information

ID 65
Name NMDA receptor (protein family or complex)
Synonyms Glutamate [NMDA] receptor; Glutamate [NMDA] receptors; N methyl D aspartate receptor; N methyl D aspartate receptors; NMDA receptor; NMDA receptors

Compound Information

ID 615
Name sodium azide
CAS sodium azide

Reference

PubMed Abstract RScore(About this table)
17316809 Marino S, Marani L, Nazzaro C, Beani L, Siniscalchi A: Mechanisms of sodium azide-induced changes in intracellular calcium concentration in rat primary cortical neurons. Neurotoxicology. 2007 May;28(3):622-9. Epub 2007 Jan 20.
An intracellular calcium ([Ca (2+)](i)) increase is involved in sodium azide (NaN (3))-induced neurotoxicity, an in vitro model of brain ischemia. In this study the questions of possible additional sources of calcium influx, besides glutamate receptor activation, and of the time-course of NaN (3) effects have been addressed by measuring [Ca (2+)](i) in rat primary cortical cultures with the FURA-2 method. Basal [Ca (2+)](i) of neuronal populations was concentration-dependently increased 30 min, but not 24h, after a 10-min NaN (3) (3-30 mM) treatment; conversely, the net increase induced by electrical stimulation (10Hz, 10s) was consistently reduced. All the above effects depended on glutamate release and consequent NMDA receptor activation, since the NMDA antagonist MK-801 (1 microM) prevented them, and the spontaneous efflux of [(3) H]-d-aspartate from superfused neurons was concentration-dependently increased by NaN (3). In single neuronal cells, NaN (3) application progressively and concentration-dependently increased [Ca (2+)](i) (to 177+/-5% and 249+/-7% of the controls, 4 and 12 min after a 10mM-treatment, respectively). EGTA (5mM) pretreatment reduced the effect of 10mM NaN (3) (to 118+/-5% at 4 min, and to 148+/-10% at 12 min, respectively), while 1 microM cyclosporin A did not. Both MK-801 and CNQX (a non-NMDA glutamate antagonist, 10 microM) prevented NaN (3) effect at 4 min (to 147+/-8% and 153+/-5%, respectively), but not at 12 min after NaN (3) treatment. Conversely, 10 microM verapamil and 0.1 microM omega-conotoxin (L- and N-type calcium channel blockers, respectively) significantly attenuated NaN (3) effects at 12 min (to 198+/-8% and 164+/-5%, respectively), but not at 4 min; the P/Q-type calcium channel blocker, agatoxin, 0.3 microM, was ineffective. These findings show that the predominant source of calcium increase induced by NaN (3) is extracellular, involving glutamate receptor activation in a first step and calcium channel (mainly of the N-type) opening in a second step.
1(0,0,0,1)